Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Oxidative Stress and Anesthesia in Diabetic Patients

Autor: Peivandi Yazdi A, Sharifian Razavi M

Publikováno v: Patient Safety and Quality Improvement Journal, Vol 2, Iss 2, Pp 94-96 (2014)

Free radical and peroxide production lead to intracellular damage. On the other hand, free radicals are used by the human immune system to defend against pathogens. The aging process could be limited by oxidative stress in the short term. Chronic dis

Externí odkaz: https://doaj.org/article/97a3f0057e9843b8b1dca8ef2f8097c0

Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model.

Autor: Hassannia H; Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari P.O. Box 48157-33971, Iran.; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran., Amiri MM; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran., Ghaedi M; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran., Sharifian RA; Department of Hematology and Oncology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran P.O. Box 14197-33141, Iran., Golsaz-Shirazi F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran., Jeddi-Tehrani M; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran P.O. Box 19839-69412, Iran., Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran P.O. Box 14155-6559, Iran.

Publikováno v: Cancers [Cancers (Basel)] 2022 Nov 26; Vol. 14 (23). Date of Electronic Publication: 2022 Nov 26.

Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.

Autor: Hadadi L; Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran., Hafezi M; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Amirzargar AA; Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Sharifian RA; Clinic of Hematology and Oncology, Vali-Asr Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Abediankenari S; Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran., Asgarian-Omran H; Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran, asgarianhossein@yahoo.com.; Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran, asgarianhossein@yahoo.com.

Publikováno v: Oncology research and treatment [Oncol Res Treat] 2019; Vol. 42 (4), pp. 202-208. Date of Electronic Publication: 2019 Mar 14.

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.

Autor: Hojjat-Farsangi M; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Jeddi-Tehrani M; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Daneshmanesh AH; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Mozaffari F; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Moshfegh A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Hematology-Oncology, Karolinska University Hospital Solna, Stockholm, Sweden., Razavi SM; Clinic of Hematology and Oncology, Firozgar Hospital, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran., Sharifian RA; Clinic of Hematology and Oncology, Vali-Asr Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Rabbani H; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Österborg A; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.; Department of Hematology-Oncology, Karolinska University Hospital Solna, Stockholm, Sweden., Mellstedt H; Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden., Shokri F; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Publikováno v: PloS one [PLoS One] 2015 Nov 12; Vol. 10 (11), pp. e0142310. Date of Electronic Publication: 2015 Nov 12 (Print Publication: 2015).